Study type

Study type

Non-interventional study

Scope of the study

Assessment of risk minimisation measure implementation or effectiveness
Non-interventional study

Non-interventional study design

Cohort
Study drug and medical condition

Anatomical Therapeutic Chemical (ATC) code

(B01AA) Vitamin K antagonists
(B01AE07) dabigatran etexilate
(B01AF) Direct factor Xa inhibitors

Medical condition to be studied

Haemorrhage
Ischaemic stroke
Acute myocardial infarction
Glaucoma
Population studied

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

44000
Study design details

Main study objective

The objective is to assess whether the implementation of a study specific CDM and a general CDM, versus using a common protocol alone has an impact on the consistency of the study results of a pharmacoepidemiologic study in real-world data.

Outcomes

TBC, TBC

Data analysis plan

TBC